Nunzia Pharmaceutical Company
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Nunzia Pharmaceutical Company generated cash of $0, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2017 | 0 | 0 | 0 |
|---|---|---|---|
| 2018 | 0 | 0 | 0 |
| 2019 | -3.8K | 0 | 3.8K |
| 2020 | -9M | 0 | 2.49K |
| 2021 | -86.77K | 0 | 86.90K |
| 2022 | 0 | 0 | 0 |
NUNZ Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 131 | 0 | -2.49K | 0 | 0 | 0 |
Operating activities | ||||||
Net income | 0 | -78.06M | -9.01M | -33.63K | -18.57K | -13.04K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 78M | 2.49K | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 78M | 2.49K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | -24.00K | 4.53K | 8.64K | 2.09K | 12.4K |
Cash generated by operating activities | 0 | -86.77K | -9M | -3.8K | 0 | 0 |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 2.49K | 3.8K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -23K | 0 | 0 | 0 |
Cash used in financing activities | 0 | 86.90K | 2.49K | 3.8K | 0 | 0 |
Net Change In Cash | 0 | 131 | -8.99M | 0 | 0 | 0 |
Cash at end of period | 131 | 131 | -9M | 0 | 0 | 0 |
| Data source | Data source | Data source |